Dr. Amor Belmeguenai, Co-Founder of GAOMA Therapeutics and Associate Professor at the University Claude Bernard Lyon 1, will attend the Neuroscience Conference organized by the Society for Neuroscience on November 12-16, 2022, in San Diego, CA, USA.
Dr. Belmeguenai will be pleased to present a poster on GAO-3-02, our first-in-class drug candidate displaying anti-seizure and pro-cognitive activity. Don’t hesitate to reach out!
The attendance to the event is supported by funding from @RegionAuvergne-Rhône-Alpes and @Lyonbiopôle.